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Abstract
Background: Access to medicines is one of the major challenges in health policy. The high out-of-pocket expenditures
on medicines in the Latin American and Caribbean (LAC) region represents important barrier to affordable access to
care for NCDs. This paper aim to identify key barriers in access to medicines for household members with a
diagnosed chronic condition in three Central America countries.
Methods: This was a cross-sectional analytic study, based on data from three household surveys using a
common methodology. We examined associated factors to: (1) seeking care for chronic illness from a trained
clinician in the formal health system, and (2) obtaining all medicines sought for the chronic conditions reported.
Results: A chronic condition was reported in 29.8 % (827) of 2761 households - 47.0, 30.7 and 11.8 % in Nicaragua,
Honduras and Guatemala, respectively. The three main chronic conditions reported were hypertension, arthritis, and
diabetes. Seeking care in the formal health system ranged from 73.4 % in Nicaragua to 83.1 % in Honduras, while full
access to medicines varied from 71.6 % in Guatemala to 88.0 % in Honduras. The main associated factors of seeking
care in the formal health system were geographic location, household head gender, Spanish literacy, patient age,
perceived health status, perceived quality of public sector care, household economic level, and having health
insurance. Seeking care in the formal health system was the main bivariate associated factor of obtaining full
access to medicines (OR: 4.3 95 % CI 2.6 – 7.0). The odds of full access to medicines were significantly higher
when the household head was older than 65 years, medicines were obtained for free, households had higher
socioeconomic status, and health care was sought in the private sector.
Conclusions: The nature of the health system plays an important role in access to medicines. Access is
better when public facilities are available and function effectively, or when private sector care is affordable.
Thus, understanding how people seek care in a given setting and strengthening key health system components will
be important strategies to improve access to medicines, especially for populations at high risk of poor access.
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Background
Access to medicines is a component of access to health
care and is considered by the World Health Organization
(WHO) as fundamental human right [1]. Medicines are
needed to achieve optimal health outcomes in a broad
range of health conditions. When medicines are not used
in a clinically effective way, they may precipitate adverse
events or result in waste of scarce financial resources,
leading to problems at individual, social, political, and eco-
nomic level [1].
Ensuring access to medicines for people who need
them is one of the major challenges in health policy, es-
pecially for non-communicable diseases (NCDs) [2, 3].
NCDs, such as cardiovascular disease, diabetes, cancer,
and chronic respiratory diseases, are the leading causes
of premature death and illness throughout the Americas.
They account for some 4.5 million deaths each year in
Latin America and the Caribbean, or 77 % of all deaths
in the Region [2, 4, 5].
High blood pressure was one of the three leading risk
factors for global disease burden, accounting for 9.4 mil-
lion deaths, 7 · 0 % of global Disability-Adjusted Life Year
(DALYs), in 2010.[6] Hypertension is one of the most
important preventable causes of premature mortality
worldwide [6] and in the American region, its prevalence
is 35 % in the overall population [5].
The global prevalence of diabetes was estimated to be
9 % among adults aged 18 years and older in 2014. [7]
In 2012, an estimated 1.1 million people died from dia-
betes. Almost 80 % of diabetes deaths occur in low- and
middle-income countries. Almost half of diabetes deaths
occur in people under the age of 70 years. In the American
region, the number of people with diabetes was estimated
at 62.8 million in 2011, and it is expected to reach the 91.1
million mark by 2030 [5]. Diabetes and its complications
have a significant economic impact on individuals, families,
health systems and countries [2, 4].
In the Latin America and Caribbean region, health ex-
penditures are estimated to account for 33 % of all
household expenditures and a large proportion of overall
health expenditures is for medicines [5]. High out-of-
pocket expenditures on medicines and high prices of
medicines in the region represent important barriers to
affordable access to care for NCDs [5].
Access to medicines is a complex phenomenon that
is deeply intertwined with access to health care
through the health system. Indeed, WHO recognizes
medicines and technologies as one of the six health
system building blocks [8]. In seeking approaches to
improve access to medicines, it is important to con-
sider a broad perspective on strengthening the health
system [9]. Most health system strengthening inter-
ventions have ignored interconnections between sys-
tem components. Consequently, population access to
medicines has typically been addressed through frag-
mented, often vertical approaches [9].
A health system approach also implies considering the
perspectives of patients, for whom the health system ex-
ists. Patients’ perceptions about access, quality of care,
and affordability as well as their ability and willingness
to pay for services drive utilization of the system, and
strengthen or circumvent policies in place. Thus, ana-
lyses of access to care in different health systems need to
recognize that health system components such as policy
frameworks, structure and geographic location of ser-
vices, health care financing, and medicines supply are in-
terrelated [9, 10].
The study entitled “Estudio del impacto de la exclusión
de la atención de salud sobre el acceso a medicamentos
en Honduras, Guatemala y Nicaragua”, hereafter re-
ferred as the source study, used, linked household sur-
veys in three Latin American countries to describe how
different population groups obtain medicines and to as-
sess the relationship between the exclusion from health
care and access to medicines [11].
In this paper, we identify key factors related to access
to medicines for treating chronic illness among persons
who were reported to have at least one chronic
condition.
Methodology
This was a cross-sectional analytic study, based on data
from a household survey conducted using methods de-
veloped by the World Health Organization (WHO) and
adapted to study the exclusion from health care and ac-
cess to medicines in Central America [11–13].
Study settings
Household surveys were conducted in three Central
American countries: Nicaragua, Honduras, and
Guatemala.
The countries were selected according to the following
criteria. (1) presented important challenges to achieve
the Millennium Development Goals related to maternal
mortality and access to health care; (2) had access to
medicines as one component of the country’s technical
cooperation agenda with PAHO/WHO; and (3) had a
public health sector with limited resources, uncertain
quality of services, and low coverage of basic public
health services.
Selected profile aspects from the country health sys-
tem are summarized in terms of social and demographic
characteristics, health services, and health indicators in
Table 1. The following sections include additional infor-
mation about the three countries, specificities and high-
lights that could not fit in Table 1.
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Nicaragua
Poverty and poor education were key social determinants
of health status in Nicaragua [14]. In 2005, the estimated
general poverty rate was 48.3 %, while an estimated 17.2 %
of the population lived in conditions of extreme poverty.
Only 52.4 % of the working age population was active in
the job market in 2005; in 2003, secondary school comple-
tion rate was 45.2 and 25.9 % of the population is unable
to read or write [14]. According to the 2005 census, 15 %
of the population self-identified as belonging to an indi-
genous group or ethnic community [14].
Diseases of the circulatory system, injuries, and tumors
accounted for the three leading causes of death and the
morbidity and mortality associated with chronic diseases
and injuries were increasing [14].
Nicaragua had no private insurance system with ex-
panded coverage [14]. Nicaraguan Social Security Insti-
tute (INSS) provided the only health insurance, which is
restricted to the formally employed population.
The Ministry of Health of Nicaragua (MINSA) has
been the primary supplier of health services. Its service
network targets primary and secondary care. The esti-
mated care coverage rates of the country’s heath institu-
tions were: MINSA (60 %); INSS (7.7 %, including
beneficiaries and their family members); Ministry of
Government and Military Health networks (8 %); and
private institutions (4 %) [14].
Essential medicines were subsidized in the public sec-
tor, the government instituted free access to health care
and medicines in the public sector in 2007 [11].
Table 1 General characteristics of study countries (Nicaragua, Honduras, and Guatemala)
NIC HON GUT
Demographica
Population [Thousands] 5,142,098 7,536,952 12,728,111
Proportion of population 60 years and older [%] 3.2 5.2 3.6
Life expectancy at birth [Years] 70.8 73.0 68.7
Declares ethnic minority (%) 15 6 41
Socio-economica
Literacy rate [%] 74.1 78.0 71.0
Gross Domestic Product (GDP), per capita, international $ (PPP-adjusted) [US$] 3262 2665 4148
Gini index 40.1 57.7 55.1
Proportion of population below the international poverty line [%] 48.3 20.7 16.0
Unemployed proportion of the labor force [%] 12.2 3.8 1.8
Health servicesb
Physicians’ ratio [10,000 hab.] 4.7 8.7 9.5
Number of outpatient care facilities [10,000 hab.] 2.2 2.8 1.2
Hospital beds ratio [per 1000 pop.] 0.9 1 0.5
Outpatient health care visits ratio [per 1000 pop.] 2154 1445 1071
Annual national health expenditure as a proportion of the GDP [%] [12] 3.7 2.0 1.4
Annual national health expenditure as a proportion of the GDP [%] (Private) 3.5 2.6 4.8
Health insurance coverage [%] 12.2 16.9 17.8
Health services coverage [%] 56.6 60.7 67.0
Health status (proportional mortality)c
Cardiovascular diseases (CVD) (%) 25 31 14
Cancers (%) 13 13 11
Respiratory diseases (%) 4 4 2
Diabetes (%) 7 5 5
Others non communicable diseases (%) 20 16 15
Deaths estimated as caused by NCDs of all deaths (%) 69 69 47
aOPS, (Organização Pan-Americana da Saúde). Saúde nas Américas - Panorama Regional y Perfiles de país. Washington, D.C.: Organização Pan-Americana da
Saúde; 2012
bPAHO, (Pan American Health Organization). Health Systems Profile in Nicaragua: Monitoring and Analyzing Health Systems Change/Reform. Washington, D. C.:
PAHO2009.; PAHO, (Pan American Health Organization). Health System Profile Honduras, Central America: Monitoring and Analysis of Health Systems Change/
Reform. Washington, D.C.:2009, PAHO, (Pan American Health Organization). Health systems profile of Guatemala. Washington, D.C2007
cWHO, (World Health Organization). Noncommunicable Diseases Country Profiles Geneva WHO, (World Health Organization) 2011
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Availability of medicines was found to be 73.7 and
84.2 % in public and private health care sector respect-
ively [11].
Honduras
In 2009, 80 % of households received only 36.8 % of the
national income, while the wealthiest 20 % receive
63.2 % [15]. There were eight culturally distinct ethnic
minorities (Lencas, Pech, Garifunas, Chortis, Tawahkas,
Tolupanes/Xicaques, Miskitos, and an English-speaking
black population), which accounted for 6 % of the popu-
lation according to the 2001 census. The areas inhabited
by the indigenous populations were some of the most
deprived areas in the country, with limited access to
basic services and infrastructure, subsistence economies,
and environment problems [15].
The epidemiological profile of Honduras has been in
transition. Infectious diseases, particularly conditions re-
lated to the respiratory and digestive systems, coexist
with chronic degenerative conditions such as cancer and
cardiovascular disease, which are more common in the
adult population [15].
Hypertension and diabetes were the first and the sixth
leading causes of specialized care in 2007, respectively.
Although there was no complete database, chronic dis-
eases constitute the leading causes of morbidity and
mortality at the national level [15].
The health sector consisted of a public subsector made
up of the Ministry of Health (SS), which played the steer-
ing and regulatory role in the sector, and the Honduran
Social Security Institute (IHSS), which was responsible for
collecting and managing fiscal resources and the required
contributions made by workers and employers. Insured
care was delivered by a mix of public and private sectors
[15]. For-profit and nonprofit institutions formed the pri-
vate subsector. Nine percent of the population was regis-
tered in the IHSS, 2.7 % has private insurance, and 88.3 %
is covered by the SS [15].
The Honduras National Medicine Policy aimed to en-
sure adequate supply of quality medicines at the lowest
possible price [11]. According to PAHO, by 2010 the
Honduras government provided free medicines for the
following health conditions: malaria, tuberculosis, sexu-
ally transmitted diseases, HIV/AIDS, and vaccines. Chil-
dren under five, pregnant women and the elderly as well
as people who have no ability to pay were also entitled
to receive medicines from the basic medicine list free of
charge in the public sector [11]. The Ministry of Industry
regulated profit margins for importers and retailers of
medicines; no other medicines price controls were in
place. Availability of medicines was found to be 79.2
and 67.4 % in public and private health care sector
respectively [11].
The IHSS purchased medicines through a centralized
process that was separated from the SS. Procurement by
the Ministry of Health was limited to medicines on the
basic list, which was equivalent to a national essential
medicines list. The IHSS limited its purchases to a sep-
arate list of medicines established by the institution [15].
Public health facilities charged a fixed fee per use, which
covers the consultation, dispensing, laboratory, and
clinic procedures [11].
Guatemala
More than half of the population lived in poverty and
nearly 16 % in extreme poverty [16], but the GDP per
capita was higher than $4000 US dollars, indicating a
high level of socioeconomic disparities among popula-
tions groups. Overall, 41 % of the population were indi-
genous and more than half lived in rural areas.
Infectious and nutritional diseases were prominent
in the country’s morbidity profile. Communicable dis-
eases were the leading cause of mortality; however,
deaths from cardiovascular diseases and tumors were
increasing [16].
Health care in the public sub-sector was under the re-
sponsibility of a network of services from the Ministry of
Public Health and Social Welfare [17] the Guatemala
Social Security Institute (IGSS), the health services of
the Ministries of Defense and Government, and the San
Carlos University [16]. Medicines were provided free of
charge to patients that cannot afford them and to the
elderly, but only during inpatient hospitalizations, while
children under five and pregnant women receive medi-
cines free in both, hospitals and ambulatory care. How-
ever, except these two groups, the others did not have
free access to continuous NCD outpatient treatment.
Consultations and medicine dispensing required a fee
per use in hospital and in ambulatory care [17]. Vaccines,
contraceptives and medicines for specific diseases, such as
malaria, tuberculosis, HIV/AIDS, sexual transmitted dis-
eases were provided free of charge to the entire population
due to their public health relevance [17]. Availability of
medicines was found to be 64.7 and 88.2 % in public and
private health care sector respectively [11].
Sampling
Methods of the source study are detailed elsewhere [13].
Briefly, the sample was designed to estimate the propor-
tions of persons excluded from health care and of those
without access to medicines. A cluster sample was se-
lected in three stages. In the first stage, 50 census tracts
were selected, with probability proportional to size,
based on the number of households; primary sampling
units were stratified according to urban/rural location.
In the second stage, 20 houses were selected in each
census tract, anticipating a 25 % non-response rate. In
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the third stage, for multi-household units, one house-
hold was selected per unit using a table of random
numbers [13].
The household survey evaluated access to health care
and medicines at the household level for three categories
of health conditions (acute, chronic, pregnancy) and also
for respondents who reported poor health status [13].
Data were collected on one case of chronic illness per
household. If the household reported more than one
case, the oldest person experiencing an illness was
selected [13].
Study variables
We examined two key outcome measures: "seeking care
in the formal health system" and “having full access to
medicines” for a chronic condition (the latter defined as
obtaining in the last month all medicines that were
sought for the chronic condition reported among those
who sought care in the formal health system).
The “formal health system” was considered here to
include clinically trained personnel working in the
health facilities of the Ministry of Health, the formal
private sector (hospitals, private clinic and private
physicians), or health facilities supported by the Social
Security System [11].
The variable “economic level” was defined based on
the number of goods in the household and the level of
education of the head of the household, combined in a
composite index [13]. This variable was categorized in
three levels (A, B, and C) corresponding to high, middle,
and low socioeconomic status, respectively.
The category “ethnic minority” was created for all
three countries from respondent-reported categories, ag-
gregating those who classified themselves as indigenous,
black, or country-specific ethnic minorities [11, 13].
In this study we used the definition for urban and
rural provided by each corresponding National Institute
of statistics, responsible for the census information, as
well as the area their map that classify the areas in urban
or rural in the field [11].
Statistical analysis
Data were analyzed with the statistical package SPSS®
V.17 using descriptive statistics and multivariable logistic
regression. First, bivariate analyses were performed to
identify the variables associated with the two outcome
variables. Results from initial analyses indicated that the
variable "seeking care in the formal health system" was
the most important associated factor of “having full ac-
cess to medicines”. In addition, the three countries had
distinct profiles concerning the most important determi-
nants of seeking care and access to medicines for
chronic diseases. Based on these preliminary analysis, we
modeled the association (odds ratio) between the two
primary outcomes and potential explanatory variables
separately for each country.
All candidate explanatory variables were tested indi-
vidually with both outcomes; multivariable logistic re-
gression models included the explanatory variables
found to be associated with the outcome variables with
p <0.10 in bivariate analyses. If more than one candidate
explanatory variables measured the same attribute (e.g.
perception of geographic accessibility and rural/urban
geographical location), the variable with the strongest
association with the outcome variable was included.
For theoretical relevance of their relationships to both,
access to health care and to medicines, the variables
measuring economic and education level of the head of
household were retained in all final multivariable
models, along with all the other associated variables that
had adjusted p < 0.10 in the multivariable models. Odds
ratio (OR) estimates are presented in the paper with
95 % confidence intervals (CI).
Overall, the variables used in the analyses had a max-
imum of 5 % missing. Given this low percentage, we did
not impute values for any missing variables, and cases
with missing data were excluded from the analyses.
Results
Overall, only about three-quarters of persons who re-
ported a chronic condition sought care in the formal
health system, ranging from 73.4 % in Nicaragua to 83.1 %
in Honduras (Table 2). Of those who sought care in the
formal health system, almost all were successful in obtain-
ing health care and they were more likely to have “full ac-
cess to medicines” for their chronic illness, (p <0.01)
Nicaragua (OR: 9.4 95 % CI 5.0 – 17.6) Honduras (OR: 6.1
95 % CI 3.0 12.4) and Guatemala (OR: 13.3 3.8 – 47.2).
Seeking care in the formal health system was the main
bivariate associated factor of obtaining full access to medi-
cines (OR: 4.3 95 % CI 2.6 – 7.0).
A majority of respondents who sought care did so in
the public sector in Nicaragua (68.3 %) and Honduras
(60.2 %), while less than half (47.6 %) did so in
Guatemala, being this aspect associated with “full access
to medicines” in Honduras (p < 0.05) and Guatemala
(p < 0.1). Most medicines were prescribed by doctors
in all three settings.
Among those reporting a chronic condition, “full ac-
cess to medicines” varied from 71.6 % in Guatemala to
88.0 % in Honduras. In all countries, the majority of
medicines were obtained in the private sector and less
than half of persons who obtained medicines received all
of them free of charge. “full access to medicines” was as-
sociated to “All medicines obtained in the public sector”
and “at least one medicines obtained in the private
sector” in Honduras (p < 0.05) and “Obtained medicines
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for free” was associated in both Nicaragua and Honduras
(p < 0.05).
Overall, 29.8 % (827) of 2761 households reported in
at least one chronic condition. In Nicaragua, Honduras
and Guatemala this percentage was 47.0, 30.7 and
11.8 % of households, respectively (Table 3).
The general socio-demographic profile was similar
across countries. Few households were overcrowded
(defined as three or more persons per room), ranging
from 3.4 % in Guatemala to 15.4 % in Nicaragua. In all
countries, households reporting a chronic health condi-
tion were located primarily in urban areas. Overall, more
than 71.0 % of households had a public health facility lo-
cated less than 30 min away, ranging from 71.0 % in
Honduras to 75.6 % in Nicaragua. Geographic accessibil-
ity of private health facilities located within 30 min var-
ied from 47.3 % in Guatemala to 52.8 % in Honduras.
Nicaragua had a much higher proportion of female
heads of household (61.1 %) compared to Honduras
(32.8 %) and Guatemala (35.4 %). Overall, few house-
holds identified the female head of household as being a
member of an ethnic minority, ranging from 6.4 % in
Guatemala to 15.1 % in Nicaragua and Honduras. In
Guatemala, 34.9 % of household heads had secondary
school education or higher, compared to 15.7 and 18.9 %
in Nicaragua and Honduras, respectively.
Respondents in all three countries reported poor
health insurance coverage, with only 14.8 % (Honduras)
to 22.4 % (Guatemala) of households covered and less
than 15 % of households in any country having health
insurance with medicines coverage (8.6 % in Honduras
and Nicaragua to 14.3 % in Guatemala).
Around 60 % of households had a positive assessment
of the geographic location, working time, quality of care,
and medicines quality in nearby public health facilities.
This proportion was somewhat higher in Honduras than
in Nicaragua or Guatemala.
In Honduras and Guatemala, the majority of people
reporting a chronic condition was female, while in
Nicaragua the majority was male (Table 4). More than
75 % of the chronic conditions reported in the survey
were in persons with age 41 and greater, which is con-
sistent with the epidemiology of chronic illness and also
with the field protocol to collect information about the
oldest person with a chronic condition in each
household.
Considering the three countries combined, 45 % of the
persons with a chronic condition reported medium or
high levels of difficulty in carrying out normal activities,
while 8 % reported extreme difficulty.
The three main chronic conditions reported were
hypertension, arthritis, and diabetes in all countries.
However, the percentage of individuals reporting each
condition varied across countries. Almost half of the
chronically ill individuals in Nicaragua (47.1 %) and
Honduras (45.7 %) reported having hypertension, compared
with a much lower percentage in Guatemala (15.5 %). Arth-
ritis, as well, was more reported in Nicaragua (39.3 %) and
Honduras (21.7 %) then in Guatemala (13.6 %). Conversely,
proportions of chronically ill individuals reporting diabetes
were higher in Guatemala (27.3 %) than in Nicaragua
(18.0 %) or Honduras (18.4 %) (Table 4). Consistent with
these conditions, the three main categories of medicines
reported were antihypertensive, anti-diabetic, and anti-
inflammatory medications.
Care seeking
In Nicaragua, bivariate analyses found that seeking
care in the formal health system was associated with
the following variables related to the household:
higher educational level, higher economic level,
urban region, vicinity to health facilities, female head
of household, retired head of the household, favor-
able perceptions about geographic location and
Table 2 Health seeking behavior and access to medicines by country
Country NIC HON GUT
Number of households with a chronic condition 450 267 110
Sought care in the formal health system (%) 73.4◊◊◊ 83.1◊◊◊ 73.8◊◊◊
Obtained health care in the health system 72.1 81.4 68.1
Sought care in the public sector (%) 68.3 60.2◊◊ 47.6◊
All medicines prescribed by a doctor (%) 88.5 88.9 89.2
Sought medicines (%) 77.5 80.1 59.9
Full access to medicines 81.3 88.0 71.6
All medicines obtained in the public sector (%) 35.6 32.1◊◊ 10.8
All medicines obtained in the private sector (%) 47.2 56.1 23.3
At least one medicine obtained in the private sector (%) 56.1 66.9◊◊ 33.3
Obtained medicines for free (%) 49.8◊◊ 33.7◊◊ 29.2
Full access to medicines◊◊◊p <0.01, ◊◊p <0.05, ◊p <0.1
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quality of care in the nearest public health facility,
household wealth attributes (electric power, own
bathroom), health insurance (head of the household and
person with chronic condition), and having health in-
surance that covers medicines for the individual with
chronic condition (significant explanatory factors are
denoted in Tables 3 and 4). In the final multivariable
model, the significant variables associated with “seek-
ing care in the formal health system” were household
located <30 min to a public health care facility (OR:
3.0 95 % CI 1.6 – 5.8), female household head (OR:
1.9 95 % CI 1.3 – 2.8), and quality of care in public
health facilities perceived as good (OR: 2.6 95 % CI
1.5 – 4.5) (Table 5).
In Honduras, households with a higher odds of seeking
care for a chronic illness in the formal health system were
those located at <30 min to a private health care facility,
with high economic level, individual with chronic condi-
tion able to read and write in Spanish, where the chronic-
ally ill person reported high or extreme difficulties in
performing daily activities, and poor perceived health sta-
tus (Tables 3 and 4). In the final multivariable model, the
significant associated variables with seeking care in the
formal health system were households with higher eco-
nomic level (OR: 2.8 95 % CI 0.9 – 9.2), individuals with
chronic condition that has literacy in Spanish (OR: 2.0
95 % CI 1.0 – 4.4), and health status perception evaluated
as fair or bad (OR: 2.7 95 % CI 1.2 – 6.5) (Table 5).
Table 3 Characteristics of households (HH) with chronic conditions and bivariate associations with the outcome variables by
country, 2010
Country NIC HON GUT
Total number of HH 957 869 935
Number (%) of HH reporting one or more chronic diseases 450 267 110
Number of persons with a chronic disease per HH [mean(SE)] 1.2 (0.5) 1.2 (0.5) 1.1 (0.5)
HH located less than 30 min for public health facility (%) 71.3*, ◊◊ 71.0 75.6
HH located less than 30 min for private health facility (%) 50.1◊◊ 52.8**,◊◊◊ 47.3
HH located in urban region (%) 62.9*** 51.4 58.9**,◊◊◊
HH with fewer than 3 persons per room (%) (overcrowding) 84.6** 90.7 96.6
Economic level * **,◊◊ **,◊◊◊
A (wealthy) 25.5 29.9 16.7
B (middle) 44.7 47.1 53.4
C (poor) 29.8 23.0 29.9
HH head is female (%) 61.1** 32.8 35.4
HH head can read and write in Spanish (%) 79.7◊◊ 75.5 85.3
Age of the head of household [mean (SE)] 52.4 (15) 54.7 (15) 51.2 (15)
HH head not an ethnic minority (%) 84.9 84.9◊◊ 93.6◊◊
HH head educational level ** ***,◊
None or less than primary school (%) 53.4 57.0 37.4
Primary school (%) 30.9 24.1 27.7
Secondary school and more (%) 15.7 18.9 34.9
Head of the household is employed (%) 25.9 27.1 25.0◊◊
Head of the household is retired (%) 12.4***,◊◊ 13.5 10.3◊
HH health insurance (%) 21.8* 14.8 22.4***,◊◊
HH health insurance that cover all medicines (%) 8.6◊◊ 8.6 14.3◊◊
Perceptions
Geographic location of public health facility is good (%) 61.4***,◊◊ 66.1 60.6◊◊
Working time of public health facility is good (%) 57.8 69.9 64.0
Working time of the pharmacy at public health facility is good (%) 56.2 68.9 69.2
Quality of the health care at public health facility is good (%) 51.5*** 64.5 45.1*
Quality of the medicines at public health facility is good (%) 61.1* 68.1 56.6
Sought health care in the health system ***p <0.01, **p <0.05, *p <0.1
Full access to medicines ◊◊◊p <0.01, ◊◊p <0.05, ◊p <0.1
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In Guatemala, household location in an urban area,
higher economic level, higher educational level, hav-
ing health insurance, positive perception of the quality
of care in the nearest public health facility, and
chronic ill individual reporting difficulty in carrying
out normal activities were the factors associated with
seeking care for chronic illness (Tables 3 and 4). In
multivariable models, the odds of seeking care were
higher for households insurance (OR: 10.5 95 % CI
1.0 – 121.3) and for those that had positive percep-
tions about the quality of care in the public health
care facility (OR: 2.8 95 % CI 1.0 – 10.1).
Access to medicines
The most important associated factor of obtaining full
access to medicines in bivariate analyses was seeking
care in the formal health system (Table 2).
Table 4 Characteristics of individuals with chronic diseases and bivariate association with the outcome variables by country, 2010
Country Nicaragua Honduras Guatemala
Number of households that report a chronic condition 450 267 110
Person with a chronic condition
Female (%) 37.2 64.5 57.3
Age [mean (SD] 52.2 (19) 51.5 (22) 50.8 (19)
Age (%) ◊ ◊◊
Under 15 4.4 8.7 6.6
16 – 40 years 19.5 18.0 18.1
41 – 64 years 49.9 43.5 54.5
65 and over 26.2◊ 29.8 20.8
Not an ethnic minority (%) 85.8 83.7 90.1◊◊
Reads/writes in Spanish (%) 78.5 73.9** 74.9◊
Relationship with the head of household **
Head of the household or spouse (%) 80.8 77.7 82.6
Son/ daughter/ grandchild / stepchild (%) 7.1 12.3 6.4
Other relative (%) 11.5 10.0 11.0
Not related (%) .5 0 0
Difficulty in carrying out normal daily activities (%) * *
None (no difficulty in carrying our normal activities) 18.9 22.1 16.4
Low 28.1 24.5 26.8
Medium 29.8 24.6 27.3
High 14.4 19.5 24.2
Extreme (cannot carry out normal activities) 8.5 9.3 2.8
Chronic condition reported (%)
Hypertension 47.1 45.7 15.5
Arthritis 39.3 21.7 13.6
Diabetes 18.0 18.4 27.3
Cardiovascular diseases 14.4 13.5 10.0
Asthma 11.6 13.5 5.5
Stomach diseases 10.7 11.6 12.7
High cholesterol 6.9 10.1 4.5
Other 14.2 18.4 13.6
Health status self-evaluated as good (%) 53.8 43.3** 41.0
Health insurance (person with chronic disease only) (%) 17.4** 11.0 13.3*,◊◊◊
Health insurance covers medicines (person with chronic disease only) (%) 14.4**,◊◊ 11.0 11.2*,◊◊◊
Sought health care in the health System ***p <0.01, **p <0.05, *p <0.1
Full access to medicines ◊◊◊p <0.01, ◊◊p <0.05, ◊p <0.1
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In Nicaragua, bivariate correlates of full access to
medicines included proximity to public and private
health facilities, literacy in Spanish, having a retired
household head, medicines insurance coverage, age
over 65, and paying for medicines. Having a household
head older than 65 years (OR: 5.3 95 % CI 1.1 – 25.4)
Table 5 Predictors from multivariable logistic regression models of seeking health care for a chronic disease in the formal health
system in Nicaragua, Honduras and Guatemala, 2010
Nicaragua
Economic and demographic variables OR CI p-value
Economic level
A (wealthy) 1.0 0.4 – 2.6 1.00
B (middle) 1.5 0.9 – 2.7 0.15
C (poor) 1.0 –
HH head educational level
Secondary school+ 2.1 0.9 – 4.6 0.07
Primary school 1.1 0.7 – 1.7 0.69
None or < primary school 1.0 –
Other individual and household variables
Household located <30 min to the public health care facility 3.0 1.6 – 5.8 0.00
Female HH head 1.9 1.3 – 2.8 0.00
Quality of care in the public health facility perceived as good 2.6 1.5 – 4.5 0.00
Honduras
Economic and demographic variables OR CI p-value
Economic level
A (wealthy) 2.8 0.9 – 9.2 0.08
B (middle) 1.9 0.9 – 4.1 0.10
C (poor) 1.0 – –
HH head educational level
Secondary school+ 0.9 0.2 – 3.6 0.89
Primary school 1.6 0.5 – 4.6 0.41
None or < primary school 1.0 –
Other individual and household variables
Literacy in Spanish (individual with chronic condition) 2.0 1.0 – 4.4 0.07
Health status perception evaluated as fair or bad 2.7 1.2 – 6.5 0.02
Guatemala
Economic and demographic variables OR CI p-value
Economic level
A (wealthy) 0.3 0.1 – 1.9 0.11
B (middle) 1.1 0.4 – 3.4 0.87
C (poor) 1.0 –
HH head educational level
Secondary school+ 2.0 0.4 – 9.9 0.40
Primary school 0.3 0.1 – 0.9 0.03
None or < primary school 1.0 –
Other individual and household variables
Health insurance (HH head) 10.5 1.0 – 121.3 0.05
Quality of care in the public health facility perceived as good 2.8 1.0 – 10.1 0.08
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and receiving all medicines free of charge (OR: 2.7
95 % CI 1.0 – 7.1) were the significant associated vari-
ables in the final multivariable model (Table 6).
In Honduras geographic proximity to a private health
facility, household economic level, head of the household
being an ethnic minority, age of the individual with
Table 6 Predictors from multivariable logistic regression models of obtaining full access to medicines for a chronic disease among
those seeking health care in the formal sector, Nicaragua, Honduras and Guatemala, 2010
Nicaragua
Economic and demographic variables OR CI p-value
Household level
Economic level
A (wealthy) 1.0 0.1 – 6.1 0.99
B (middle) 1.1 0.3 – 3.4 0.89
C (poor) 1.0 –
HH head educational level
Secondary school+ 1.2 0.4 – 7.0 0.81
Primary school 1.1 0.4 – 3.7 0.88
None or < primary school 1.0 –
Other individual and household variables
65 years and over 5.3 1.1 – 25.4 0.04
Had all medicines for free 2.7 1.0 – 7.1 0.05
Honduras
Economic and demographic variables OR CI p-value
Household level
Economic level
A (wealthy) 5.1 2.1– 12.3 0.00
B (middle) 1.2 0.5 – 3.3 0.72
C (poor) 1.0 –
HH head educational level
Secondary school+ 0.4 0.2 – 1.0 0.03
Primary school 3.5 0.7 – 17.2 0.13
None or < primary school 1.0 –
Other individual and household variables
Obtained at least one medicine in the private sector 2.4 1.0 – 6.3 0.06
Guatemala
Economic and demographic variables OR CI p-value
Household level
Economic level
A (wealthy) 3.7 0.4 – 39.3 0.27
B (middle) 2.0 0.6 – 6.8 0.27
C (poor) 1.0 –
HH head educational level
Secondary school+ 3.4 1.0 – 13.2 0.06
Primary school 0.8 0.2 – 2.6 0.75
None or < primary school 1.0 –
Other individual and household variables
Sought health care in the private sector in a chronic condition 3.1 1.1 – 8.8 0.03
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chronic condition, receiving free medicines, seeking care
in the private sector, and obtaining medicines in the pri-
vate sector were the main bivariate associated factors of
full access to medicines. In the final multivariable model,
household economic level (OR: 5.1 95 % CI 2.1 – 12.3)
and obtaining at least one medicine in the private sector
(OR: 2.4 95 % CI 1.0 – 6.3) were the significant associ-
ated variables of full access to medicines (Table 6).
In Guatemala urban location of the household, higher
economic level, not being a member of an ethnic minor-
ity, higher educational level, being employed or retired,
having health insurance, having positive perception
about the geographic accessibility of a public health fa-
cility, and seeking care in the private sector were the
main associated variables of having full access to medi-
cines. In multivariable models, the odds of having full
access to medicines were significantly higher for those
who sought health care in the private sector (OR: 3.1
95 % CI 1.1 – 8.8) and who had a higher educational
level (OR: 3.4 95 % CI 1.0 – 13.2 ) (Table 6).
In general, the main reasons reported for not obtain-
ing full access to medicines were similar in all countries
(data not shown). These included “do not have money”
(66.9 %), “medicines were not available at the pharmacy
or health care facility” (18.9 %) and “prices of medicines
are high” (15.6 %).
Discussion
Access to medicines is a complex phenomenon, embed-
ded in an equally complex health system [7]. The main
associated factor of obtaining access to medicines for
treating chronic illness in these three Latin America
countries was seeking care in the formal health system.
Despite the informal availability of medicines in these
settings, most people use the formal health care system
to seek care for NCDs. This indicates that promoting an
accessible and functioning health system will be a sound
strategy to enhance access to medicines for individuals
with chronic disease.
The percentages of households reporting a chronic ill-
ness in these surveys were lower than those previously
found in Brazil (43.8 %) [18], Oman (44.4 %) [19] and
Philippines (39.0 %) [20] in similar surveys, but higher
than rates found in surveys in Ghana (16 %) [21] and
Nigeria [22]. The countries in the current study have a
relatively young population [5], which may explain the
low percentages of respondents reporting a household
member with a chronic disease. Notably, the survey re-
quired patients to have a prior diagnosis of chronic ill-
ness by a trained health worker as a criterion for entry
to the study. Low diagnostic capacity in these health sys-
tems could have led to an underestimation of the num-
ber of cases of chronic disease. The most common
diseases reported (hypertension, arthritis, diabetes) were
similar to those found in other studies [18–22] and also
to those reported in previous studies of health in the
Americas [5].
The health seeking behavior in a chronic condition is
quite different from in acute condition. This study re-
sults pointed out that overall more than 70 % of the in-
dividuals with chronic condition sough care in the
formal health system. The literature points out that in
an acute condition, this percentage is lower, less than
50 % [12] and 30 % [23] sought care for acute condi-
tions, being the perception of severity one of the associ-
ated factors [12, 23].
In these three settings, most people who sought care
were able to obtain full access to medicines for chronic
conditions. Nevertheless, the percentages of individuals
who reported full access to medicines were lower than
rates found in other studies in the Americas (89.6 % in
Brazil [24] and 97 % in [25], but similar to rates in two
states in Brazil (81 % among the elderly [26] and
Colombia (75.1 %) [27].
Spending for health care is an important component
of overall household spending in many countries, and
having to pay for health care is a key source of economic
burden and impoverishment for many of the poorest
members of the population [28–31]. Demand for medi-
cines tends to be particularly inelastic and people are
often willing to sell assets or ask for credit to afford
them [32, 33]. Treating chronic illness can present a
continuous drain on financial resources, with medicines
expenditures constituting a substantial proportion of
overall health spending [2, 4, 34–36]. Social protection
for health care through a well-functioning public sector
or widespread insurance coverage is lacking for a signifi-
cant proportion of the population in Latin America and
the Caribbean [13, 28, 37]; indeed, affordability of care
proved to be an important problem in the countries ad-
dressed in this study. Chronically ill people are especially
vulnerable since they require continuous care and im-
paired health status may also diminish their ability to
work, leading to a vicious cycle of impoverishment and
poor health.
Medicines were available free of charge to the elderly
population in Nicaragua and Honduras, yet many elderly
people were found to have paid for their medicines. This
may point to the existence of other barriers to accessing
services, including low education and health literacy,
poor geographic and functional accessibility, inefficien-
cies in the public sector medicines supply system, and
negative perceptions about public sector service quality.
Indeed, availability of medicines was found to be low in
the three countries, always below or around 80 %, both
in public and in private sector. The economic level of
households was a significant determinant of access to
medication except in Nicaragua, which was the only one
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of the three countries to guarantee free provision of
medicines to the general population. Nevertheless, even
there, less than half of respondents received medicines
free of charge.
Geographical barriers (distance and transportation dif-
ficulties), economic factors (cost of consultation and
medicines), and cultural barriers (Spanish illiteracy, be-
liefs about illnesses and treatments) have been identified
as barriers to access to health services in other studies in
Central America [13, 38, 39].
A high percentage of individuals sought care in the
formal health sector in all three countries, but about one
in five who reported having a chronic illness did not do
so. Chronic diseases typically require continuous access
to health care and medicines to prevent poor health out-
comes. The primary reasons reported for not seeking
care tended to be financial. However, other aspects of
the health system such as a low or inadequate geograph-
ical coverage, poor quality of health services (real or per-
ceived), and inefficient patterns of health seeking
behavior may also explain the failure to seek care. Health
insurance coverage was low in all three countries; this
has been identified in the literature as a major barrier to
access to health care and medicines [28, 40–43].
Care-seeking behavior is strongly related to individ-
uals’ overall perceptions about their health status, sever-
ity of illnesses, and the consequences of not treating
them. In addition, care-seeking may reflect beliefs about
the quality of the health care services or ability to over-
come perceived barriers to access [40, 44–46]. Under-
standing more about the reasons why people do not
seek care or seek care in settings where treatment is not
free are important topics for future research.
The number of people who identified themselves as an
ethnic minority was lower than expected, especially in
Guatemala; this may have been due to underrepresenta-
tion of areas with high concentrations of ethnic minor-
ities in these studies due to sample design, or to
underreporting of belonging to an ethnic group. Never-
theless, persons with chronic illness who identified
themselves as ethnic minorities were less likely in bi-
variate analyses to seek care and to receive medicines,
a finding which has been mentioned in the literature
[13, 38, 39, 47]. However, ethnicity was not a signifi-
cant associated factor in the final multivariable model
due to its correlation with stronger associated factors
such as household income and geographic distance
from health facilities. Nevertheless, it is important to
understand how being in an ethnic minority affects
seeking care and obtaining access to medicines, since
this represents an important equity issue.
The reliability and efficiency of the public sector may
have substantial impact as on availability and quality of
medicines [48]. Previous studies have shown that both
availability and cost of medicines are higher in the pri-
vate sector regardless of country [5, 49, 50]. More than
half of medicines in these surveys were obtained in the
private sector. The cost of treating chronic illness in the
region is generally more than one day of work at a mini-
mum wage [5, 49, 50]. Low public sector availability of
free medicines combined with high private sector prices
may constitute a substantial barrier in access to medi-
cines in these countries, especially in light of low cover-
age of health insurance.
Our findings indicate the need of more harmonization
between health and pharmaceutical policies. Social pro-
tection mechanisms, including insurance coverage of
medicines and provision of free medicines in the public
sector, are strategies to improve access. In addition,
other barriers to medicines access such as geographical
accessibility and perceived quality of care also call for
public policy interventions, combined with educational
campaigns and partnerships with the civil society.
Our findings suggest that optimal policy approaches to
improve access to medicines may differ by country
health system context. Taking in account the health sys-
tems perspective was useful in shedding light on some
key linkages. As example, In Nicaragua, despite the high-
est unemployment and proportion of people below pov-
erty line among the three countries, had the highest
ratio of public health expenditure and also free access to
medicines for the overall population. In this country,
most health care was provided in public health facilities
and the main determinants for seeking health care were
location and perceived quality of services. The free
provision of medicines to the general population was an
important determinant for full access to medicines. In
Honduras, where a flat copayment rate was in place for
health care and medicines, perceived need and economic
status were important determinants for seeking health
care and private pharmacies were the main source for
medicines.
In Guatemala, with the highest ratio of physicians per
capita among the three countries, had high private sec-
tor utilization. Indeed, health insurance coverage was an
important determinant for seeking health care, and eco-
nomic status and level of education were associated with
access to medicines.
As household survey linked to secondary data, the
current study may have limited external validity. The
study was not designed to infer causality, since the
exposures and outcomes were simultaneously assessed
and no temporal relationships were assessed [51, 52].
When considering population characteristics such as
gender or ethnicity. The temporal nature of the
exposure-outcome association is more plausible. How-
ever, for factors such as economic level, reverse caus-
ality is possible, e.g., if limited access to medicines
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leads to reduced economic circumstances. Access to
medicines is a complex concept and there may be di-
verse pathways through which associated factors
operate.
Limitations also include the relatively small sample
size, the inclusion of specific geographic areas in each
country, and underrepresentation of ethnic minorities,
especially in Guatemala. Additionally some country-
specific results were not as expected, such as the associ-
ation between education and access to medicines in
Honduras, where households with more highly educated
heads were less likely to have access to medicines. One
possible hypothesis is that public programs might in-
crease access to medicines for the less well-educated
part of the population that accesses care in public
facilities.
We used a health system perspective in exploring
the relationships among different health system fac-
tors on household access to medicines, but we missed
information from other stakeholders such as health
providers or policy makers. Nevertheless, we believe
this is an important approach, since end users are the
reason for the existence of health systems. Despite
possible inconsistencies in the information they pro-
vide, the perceptions of household respondents pro-
vide a window on how they interact with the health
system.
Despite these limitations, the study was successful
in identifying key barriers in access to medicines for
household members with a diagnosed chronic condi-
tion in three Central America countries.
Conclusion
These results increase our understanding of the most
significant barriers to access to the formal health sec-
tor and to medicines in three different settings in
Latin America, and they suggest policies and strat-
egies that could increase access to medicines and
equity. A health system perspective was helpful in un-
derstanding findings. Seeking care in the formal
health system was the main determinant of access to
medicines for chronic conditions. Thus, strengthening
health systems and improving community perceptions
about quality of care will be important strategies to
improve access to medicines. This is especially true
for people at high risk, such as those living in rural
areas, women, ethnic minorities, and those with low
education or economic disadvantage. Among the poor
in these surveys, most people paid out of pocket for
their medicines. Expanding insurance coverage and
other types of social protection will assure greater ac-
cess to medicines among those who cannot currently
afford them.
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